Principal Financial Group Inc Standard Biotools Inc. Transaction History

Principal Financial Group Inc

$1.66 Trillion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$1.42 - $2.35 $13,637 - $22,569	-9,604 Reduced 29.92%	22,493 $43,000
Q2 2024 Jul 29, 2024	BUY	$1.65 - $2.92 $52,960 - $93,723	32,097 New	32,097 $56,000
Q3 2022 Nov 09, 2022	SELL	$1.1 - $2.06 $28,837 - $54,004	-26,216 Reduced 52.12%	24,088 $26,000
Q2 2022 Aug 10, 2022	SELL	$1.6 - $3.99 $5,577 - $13,909	-3,486 Reduced 6.48%	50,304 $80,000
Q1 2022 May 09, 2022	SELL	$2.8 - $3.96 $65,525 - $92,671	-23,402 Reduced 30.32%	53,790 $193,000
Q4 2021 Feb 09, 2022	SELL	$3.63 - $6.13 $689,064 - $1.16 Million	-189,825 Reduced 71.09%	77,192 $303,000
Q3 2021 Nov 09, 2021	SELL	$5.5 - $7.41 $23,551 - $31,729	-4,282 Reduced 1.58%	267,017 $1.76 Million
Q2 2021 Aug 10, 2021	BUY	$4.35 - $6.35 $157,831 - $230,397	36,283 Added 15.44%	271,299 $1.67 Million
Q1 2021 May 10, 2021	BUY	$3.94 - $7.09 $70,407 - $126,698	17,870 Added 8.23%	235,016 $1.06 Million
Q4 2020 Feb 08, 2021	BUY	$5.45 - $8.65 $965,783 - $1.53 Million	177,208 Added 443.71%	217,146 $1.3 Million
Q3 2020 Nov 06, 2020	BUY	$4.34 - $11.43 $82,273 - $216,678	18,957 Added 90.35%	39,938 $296,000
Q2 2020 Aug 05, 2020	SELL	$1.85 - $5.29 $85,192 - $243,604	-46,050 Reduced 68.7%	20,981 $84,000
Q1 2020 May 12, 2020	BUY	$1.24 - $4.35 $2,370 - $8,317	1,912 Added 2.94%	67,031 $170,000
Q4 2019 Feb 05, 2020	BUY	$2.3 - $5.12 $29,334 - $65,300	12,754 Added 24.36%	65,119 $227,000
Q3 2019 Nov 13, 2019	BUY	$4.63 - $12.15 $62,597 - $164,268	13,520 Added 34.8%	52,365 $243,000
Q2 2019 Aug 12, 2019	BUY	$11.49 - $14.17 $446,329 - $550,433	38,845 New	38,845 $479,000

Others Institutions Holding LAB

# of Institutions

142

Shares Held

279M

Call Options Held

27.2K

Put Options Held

34.1K

View Full List

About STANDARD BIOTOOLS INC.

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $144M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

More about LAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account